Interleukin-10 mediated immune regulation after stem cell transplantation: Mechanisms and implications for therapeutic intervention
Tài liệu tham khảo
MacDonald, 2017, Cytokine mediators of chronic graft-versus-host disease, J. Clin. Invest., 127, 2452, 10.1172/JCI90593
Zeiser, 2017, Acute graft-versus-host disease – biologic process, prevention, and therapy, N. Engl. J. Med., 377, 2167, 10.1056/NEJMra1609337
Morris, 2007, Advances in the understanding of acute graft-versus-host disease, Br. J. Haematol., 137, 3, 10.1111/j.1365-2141.2007.06510.x
Markey, 2014, The biology of graft-versus-host disease: experimental systems instructing clinical practice, Blood, 124, 354, 10.1182/blood-2014-02-514745
Fiorentino, 1989, Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones, J. Exp. Med., 170, 2081, 10.1084/jem.170.6.2081
Moore, 2001, Interleukin-10 and the interleukin-10 receptor, Annu. Rev. Immunol., 19, 683, 10.1146/annurev.immunol.19.1.683
Shouval, 2014, Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans, Adv. Immunol., 122, 177, 10.1016/B978-0-12-800267-4.00005-5
Kuhn, 1993, Interleukin-10-deficient mice develop chronic enterocolitis, Cell, 75, 263, 10.1016/0092-8674(93)80068-P
Glocker, 2009, Inflammatory bowel disease and mutations affecting the interleukin-10 receptor, N. Engl. J. Med., 361, 2033, 10.1056/NEJMoa0907206
Lin, 2005, Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor, Blood, 106, 3995, 10.1182/blood-2004-11-4338
Abraham, 2015, IL-10 exacerbates xenogeneic GVHD by inducing massive human T cell expansion, Clin. Immunol., 156, 58, 10.1016/j.clim.2014.11.004
Blazar, 1998, Interleukin-10 dose-dependent regulation of CD4+ and CD8+ T cell-mediated graft-versus-host disease, Transplantation, 66, 1220, 10.1097/00007890-199811150-00018
Zhang, 2017, Eomesodermin promotes the development of type 1 regulatory T (TR1) cells, Sci. Immunol., 2, 10.1126/sciimmunol.aah7152
Bacchetta, 2014, Immunological outcome in Haploidentical-HSC transplanted patients treated with IL-10-anergized donor T cells, Front. Immunol., 5, 16, 10.3389/fimmu.2014.00016
Morris, 2004, Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance, Blood, 103, 3573, 10.1182/blood-2003-08-2864
Liu, 2015, IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects, Leukemia, 29, 939, 10.1038/leu.2014.310
Tawara, 2012, Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation, Proc. Natl. Acad. Sci. U. S. A., 109, 564, 10.1073/pnas.1117665109
Zhang, 2015, ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease, Sci. Transl. Med., 7, 10.1126/scitranslmed.aab0166
Foley, 2008, Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells, Biol. Blood Marrow Transplant., 14, 959, 10.1016/j.bbmt.2008.06.007
Yoshizaki, 2012, Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions, Nature, 491, 264, 10.1038/nature11501
Peng, 2018, Umbilical cord blood transplantation corrects very early-onset inflammatory bowel disease in Chinese patients with IL10RA-associated immune deficiency, Inflamm. Bowel Dis., 24, 1416, 10.1093/ibd/izy028
Spencer, 1998, The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor, J. Exp. Med., 187, 571, 10.1084/jem.187.4.571
Rubtsov, 2008, Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces, Immunity, 28, 546, 10.1016/j.immuni.2008.02.017
Roers, 2004, T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation, J. Exp. Med., 200, 1289, 10.1084/jem.20041789
Zigmond, 2014, Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis, Immunity, 40, 720, 10.1016/j.immuni.2014.03.012
de Waal Malefyt, 1991, Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression, J. Exp. Med., 174, 915, 10.1084/jem.174.4.915
D’Andrea, 1993, Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells, J. Exp. Med., 178, 1041, 10.1084/jem.178.3.1041
Li, 2015, IL-10 engages macrophages to shift Th17 cytokine dependency and pathogenicity during T-cell-mediated colitis, Nat. Commun., 6, 6131, 10.1038/ncomms7131
Ip, 2017, Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages, Science, 356, 513, 10.1126/science.aal3535
Shouval, 2014, Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function, Immunity, 40, 706, 10.1016/j.immuni.2014.03.011
Kamanaka, 2011, Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology, J. Exp. Med., 208, 1027, 10.1084/jem.20102149
Asseman, 1999, An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation, J. Exp. Med., 190, 995, 10.1084/jem.190.7.995
Krause, 2015, IL-10-producing intestinal macrophages prevent excessive antibacterial innate immunity by limiting IL-23 synthesis, Nat. Commun., 6, 7055, 10.1038/ncomms8055
Laidlaw, 2017, Interleukin-10 from CD4(+) follicular regulatory T cells promotes the germinal center response, Sci. Immunol., 2, 10.1126/sciimmunol.aan4767
Ostmann, 2013, Regulatory T cell-derived IL-10 ameliorates crescentic GN, J. Am. Soc. Nephrol., 24, 930, 10.1681/ASN.2012070684
Aschenbrenner, 2018, An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells, Nat. Immunol., 19, 1126, 10.1038/s41590-018-0200-5
Brockmann, 2018, Molecular and functional heterogeneity of IL-10-producing CD4(+) T cells, Nat. Commun., 9, 5457, 10.1038/s41467-018-07581-4
Trandem, 2011, Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis, J. Immunol., 186, 3642, 10.4049/jimmunol.1003292
Blair, 2010, CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients, Immunity, 32, 129, 10.1016/j.immuni.2009.11.009
Yao, 2015, Tr1 cells, but not Foxp3+ regulatory t cells, suppress NLRP3 inflammasome activation via an IL-10-dependent mechanism, J. Immunol., 195, 488, 10.4049/jimmunol.1403225
Fu, 2004, TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors, Am. J. Transplant., 4, 1614, 10.1111/j.1600-6143.2004.00566.x
Maynard, 2007, Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10, Nat. Immunol., 8, 931, 10.1038/ni1504
Marie, 2005, TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells, J. Exp. Med., 201, 1061, 10.1084/jem.20042276
Cretney, 2011, The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells, Nat. Immunol., 12, 304, 10.1038/ni.2006
Xu, 2018, c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont, Nature, 554, 373, 10.1038/nature25500
Groux, 1997, A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, 389, 737, 10.1038/39614
Neumann, 2014, Role of Blimp-1 in programing Th effector cells into IL-10 producers, J. Exp. Med., 211, 1807, 10.1084/jem.20131548
Montes de Oca, 2016, Blimp-1-dependent IL-10 production by Tr1 cells regulates TNF-mediated tissue pathology, PLoS Pathog., 12, e1005398, 10.1371/journal.ppat.1005398
Mascanfroni, 2015, Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha, Nat. Med., 21, 638, 10.1038/nm.3868
Gagliani, 2013, Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells, Nat. Med., 19, 739, 10.1038/nm.3179
Apetoh, 2010, The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27, Nat. Immunol., 11, 854, 10.1038/ni.1912
Karwacz, 2017, Critical role of IRF1 and BATF in forming chromatin landscape during type 1 regulatory cell differentiation, Nat. Immunol., 18, 412, 10.1038/ni.3683
Gruarin, 2019, Eomesodermin controls a unique differentiation program in human IL-10 and IFN-gamma coproducing regulatory T cells, Eur. J. Immunol., 49, 96, 10.1002/eji.201847722
Vasanthakumar, 2013, IL-27 paves different roads to Tr1, Eur. J. Immunol., 43, 882, 10.1002/eji.201343479
Iwasaki, 2013, Egr-2 transcription factor is required for Blimp-1-mediated IL-10 production in IL-27-stimulated CD4+ T cells, Eur. J. Immunol., 43, 1063, 10.1002/eji.201242942
Matsumoto, 2014, Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation, Immunity, 41, 1040, 10.1016/j.immuni.2014.10.016
Stockinger, 2009, Modulation of Th17 development and function by activation of the aryl hydrocarbon receptor--the role of endogenous ligands, Eur. J. Immunol., 39, 652, 10.1002/eji.200839134
Ho, 1998, c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms, J. Exp. Med., 188, 1859, 10.1084/jem.188.10.1859
Gagliani, 2015, Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation, Nature, 523, 221, 10.1038/nature14452
Tedder, 2015, B10 cells: a functionally defined regulatory B cell subset, J. Immunol., 194, 1395, 10.4049/jimmunol.1401329
Lal, 2016, IL-10 from marginal zone precursor B cells controls the differentiation of Th17, Tfh and Tfr cells in transplantation tolerance, Immunol. Lett., 170, 52, 10.1016/j.imlet.2016.01.002
Rosser, 2014, Regulatory B cells are induced by gut microbiota-driven interleukin-1beta and interleukin-6 production, Nat. Med., 20, 1334, 10.1038/nm.3680
Flores-Borja, 2013, CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation, Sci. Transl. Med., 5, 10.1126/scitranslmed.3005407
Iwata, 2011, Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, 117, 530, 10.1182/blood-2010-07-294249
Chaudhry, 2011, Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation, Immunity, 34, 566, 10.1016/j.immuni.2011.03.018
Brockmann, 2017, IL-10 receptor signaling is essential for TR1 cell function in vivo, J. Immunol., 198, 1130, 10.4049/jimmunol.1601045
Hooper, 2012, Interactions between the microbiota and the immune system, Science, 336, 1268, 10.1126/science.1223490
Taniki, 2018, Intestinal barrier regulates immune responses in the liver via IL-10-producing macrophages, JCI Insight, 3, 10.1172/jci.insight.91980
Sun, 2018, Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis, Nat. Commun., 9, 3555, 10.1038/s41467-018-05901-2
Yu, 2017, Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development, Proc. Natl. Acad. Sci. U. S. A., 114, 10443, 10.1073/pnas.1705599114
Kim, 2016, Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine, Science, 351, 858, 10.1126/science.aac5560
Jeon, 2012, Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon, PLoS Pathog., 8, e1002714, 10.1371/journal.ppat.1002714
Burrello, 2018, Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells, Nat. Commun., 9, 5184, 10.1038/s41467-018-07359-8
Duque-Correa, 2019, Exclusive dependence of IL-10Ralpha signalling on intestinal microbiota homeostasis and control of whipworm infection, PLoS Pathog., 15, e1007265, 10.1371/journal.ppat.1007265
Quiros, 2017, Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling, J. Clin. Invest., 127, 3510, 10.1172/JCI90229
Singh, 2014, Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis, Immunity, 40, 128, 10.1016/j.immuni.2013.12.007
Singh, 2016, Dietary indoles suppress delayed-type hypersensitivity by inducing a switch from proinflammatory Th17 cells to anti-inflammatory regulatory T cells through regulation of MicroRNA, J. Immunol., 196, 1108, 10.4049/jimmunol.1501727
Holler, 2000, Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation, Bone Marrow Transplant., 25, 237, 10.1038/sj.bmt.1702126
Cho, 2015, Association between interleukin-10 promoter gene polymorphisms and acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis, Hematology, 20, 121, 10.1179/1607845414Y.0000000183
Lin, 2003, Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation, N. Engl. J. Med., 349, 2201, 10.1056/NEJMoa022060
Perobelli, 2016, G-CSF-induced suppressor IL-10+ neutrophils promote regulatory T cells that inhibit graft-versus-host disease in a long-lasting and specific way, J. Immunol., 197, 3725, 10.4049/jimmunol.1502023
MacDonald, 2014, Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10, J. Immunol., 192, 3180, 10.4049/jimmunol.1302315
Anasetti, 2012, Marrow Transplant Clinical Trials, Peripheral-blood stem cells versus bone marrow from unrelated donors, N. Engl. J. Med., 367, 1487, 10.1056/NEJMoa1203517
Bacchetta, 1994, High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells, J. Exp. Med., 179, 493, 10.1084/jem.179.2.493
Takatsuka, 1999, Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation, Bone Marrow Transplant., 24, 1005, 10.1038/sj.bmt.1702010
Sakata, 2001, Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease, Bone Marrow Transplant., 27, 1153, 10.1038/sj.bmt.1703060
Rowe, 2006, Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation, Blood, 108, 2485, 10.1182/blood-2006-04-016063
Weber, 2014, Donor and host B cell-derived IL-10 contributes to suppression of graft-versus-host disease, Eur. J. Immunol., 44, 1857, 10.1002/eji.201344081
Chan, 2018, NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD, Eur. J. Immunol., 48, 316, 10.1002/eji.201747134
Weston, 2006, Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD, Bone Marrow Transplant., 37, 207, 10.1038/sj.bmt.1705218
Tawara, 2012, Donor- but not host-derived interleukin-10 contributes to the regulation of experimental graft-versus-host disease, J. Leukoc. Biol., 91, 667, 10.1189/jlb.1011510
Chakupurakal, 2017, Regulatory B10 cells display an altered homoeostasis in acute graft-versus-host disease, Eur. J. Haematol., 98, 128, 10.1111/ejh.12810
Matsuoka, 2010, Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation, J. Clin. Invest., 120, 1479, 10.1172/JCI41072
Zhou, 2016, A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease, J. Clin. Invest., 126, 3541, 10.1172/JCI80874
Pearce, 2003, Control of effector CD8+ T cell function by the transcription factor Eomesodermin, Science, 302, 1041, 10.1126/science.1090148
Rose-John, 2018, Interleukin-6 family cytokines, Cold Spring Harb. Perspect. Biol., 10, 10.1101/cshperspect.a028415
Stumhofer, 2007, Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10, Nat. Immunol., 8, 1363, 10.1038/ni1537
McGeachy, 2007, TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology, Nat. Immunol., 8, 1390, 10.1038/ni1539
Kennedy, 2014, Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial, Lancet Oncol., 15, 1451, 10.1016/S1470-2045(14)71017-4
Hill, 2010, Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma, Blood, 116, 819, 10.1182/blood-2009-11-256495
Alexander, 2014, CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease, J. Clin. Invest., 124, 4266, 10.1172/JCI75935
Zeiser, 2018, B-cell targeting in chronic graft-versus-host disease, Blood, 131, 1399, 10.1182/blood-2017-11-784017
Lal, 2015, Interleukin-10 from marginal zone precursor B-cell subset is required for costimulatory blockade-induced transplantation tolerance, Transplantation, 99, 1817, 10.1097/TP.0000000000000718
Le Huu, 2013, Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease, Blood, 121, 3274, 10.1182/blood-2012-11-465658
Matsushita, 2018, BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance, Sci. Adv., 4, eaas9944, 10.1126/sciadv.aas9944
de Masson, 2015, CD24(hi)CD27(+) and plasmablast-like regulatory B cells in human chronic graft-versus-host disease, Blood, 125, 1830, 10.1182/blood-2014-09-599159
Sarvaria, 2016, IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation, Blood, 128, 1346, 10.1182/blood-2016-01-695122
Facciotti, 2016, IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus, J. Allergy Clin. Immunol., 137, 318, 10.1016/j.jaci.2015.06.044
Caielli, 2019, A CD4(+) T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate, Nat. Med., 25, 75, 10.1038/s41591-018-0254-9
Sumitomo, 2017, Identification of tonsillar CD4(+)CD25(-)LAG3(+) T cells as naturally occurring IL-10-producing regulatory T cells in human lymphoid tissue, J. Autoimmun., 76, 75, 10.1016/j.jaut.2016.09.005
Koyama, 2015, Donor colonic CD103+ dendritic cells determine the severity of acute graft-versus-host disease, J. Exp. Med., 212, 1303, 10.1084/jem.20150329
Hill, 2000, The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation, Blood, 95, 2754, 10.1182/blood.V95.9.2754.009k25_2754_2759
van Bekkum, 1974, Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora, J. Natl. Cancer Inst., 52, 401, 10.1093/jnci/52.2.401
Varelias, 2017, Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome, Blood, 129, 2172, 10.1182/blood-2016-08-732628
Bacchetta, 2010, Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy, Haematologica, 95, 2134, 10.3324/haematol.2010.025825
Pellerin, 2018, APVO210: a bispecific anti-CD86-IL-10 fusion protein (ADAPTIR) to induce antigen-specific T regulatory type 1 cells, Front. Immunol., 9, 881, 10.3389/fimmu.2018.00881
Chihara, 2016, Differentiation and characterization of Tr1 cells, Curr. Protoc. Immunol., 113, 3, 10.1002/0471142735.im0327s113
Locafaro, 2017, IL-10-engineered human CD4(+) Tr1 cells eliminate myeloid leukemia in an HLA class I-dependent mechanism, Mol. Ther., 25, 2254, 10.1016/j.ymthe.2017.06.029
Clemente-Casares, 2016, Expanding antigen-specific regulatory networks to treat autoimmunity, Nature, 530, 434, 10.1038/nature16962
Gabrysova, 2009, Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells, J. Exp. Med., 206, 1755, 10.1084/jem.20082118